Dr. Robert Edward Flandry Jr., MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1075 Boiling Springs Rd, Spartanburg, SC 29303 Phone: 864-583-7265 |
Dr. Cavert Keith Mccorkle, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1075 Boiling Springs Rd, Spartanburg, SC 29303 Phone: 864-583-7265 Fax: 864-591-0422 |
Dr. Phillip George Esce, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1075 Boiling Springs Rd, Spartanburg, SC 29303 Phone: 864-560-6880 |
Dr. Christopher Chittum, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1075 Boiling Springs Rd, Spartanburg, SC 29303 Phone: 864-583-7265 |
Dr. Darwin W Keller, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1075 Boiling Springs Rd, Spartanburg, SC 29303 Phone: 864-583-7265 |
Donald C Shields, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1330 Boiling Springs Rd Ste 1600, Spartanburg, SC 29303 Phone: 864-582-6396 Fax: 864-582-1608 |
News Archive
CarThera, a French company based at the Brain and Spine Institute, that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the publication in Science Translational Medicine of a scientific paper on initial successes in disrupting the blood-brain barrier (BBB) with the use of ultrasound.
NEBioCalculator, a new online "conversions and calculations" tool developed by New England Biolabs, offers bench-side support for molecular biology experimental planning.
Rethink Autism, an educational technology company that produces online research-based treatment tools for parents and professionals, offers some suggestions and a free online set of video tips to help families address some of these challenges and enjoy the holidays.
In an expansion of its ongoing effort to promote the next generation of stem cell scientists, The New York Stem Cell Foundation (NYSCF) today named the first six NYSCF Investigators. Each of the NYSCF-Robertson and NYSCF-Helmsley Investigators will receive up to $1.5 million over the next five years to expand their own laboratories, train other scientists and foster innovative high-risk/high reward research to explore the therapeutic potential of stem cells derived from humans and model organisms.
› Verified 4 days ago